Description

The corporation has invested USD 12 million to develop a topical gel that can prevent the transmission of HIV. The research was carried out at a major University. The gel is based on antibodies that bind to the mucins coating and the mucosa tissue. The gel is mass produced and extremely cost effective.

Register now to learn more about this business. Registration is free and takes only a few seconds.

Register Now

Already a DealStream member? .